Robert P. Ragusa
CIK: 0001222644
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Sep 1, 2026ALMR
Alamar Biosciences, Inc.
Award(A)Direct5.7K shares- - Apr 8, 2026GRAL
GRAIL, Inc.
Sale(S)Direct123.5K shares at avg. $49.92$6.2M - Mar 9, 2026GRAL
GRAIL, Inc.
Sale(S)Direct7.2K shares at avg. $47.93$345K - Mar 9, 2026GRAL
GRAIL, Inc.
Sale(S)Direct258 shares at avg. $46.73$12K - Mar 5, 2026GRAL
GRAIL, Inc.
Sale(S)Direct980 shares at avg. $53.01$52K - Mar 2, 2026GRAL
GRAIL, Inc.
Sale(S)Direct35.8K shares at avg. $50.09$1.8M - Mar 2, 2026GRAL
GRAIL, Inc.
Sale(S)Direct1.7K shares at avg. $51.84$89K - Feb 5, 2026TWST
Twist Bioscience Corp
Award(A)Direct5.1K shares- - Dec 3, 2025GRAL
GRAIL, Inc.
Sale(S)Direct14.8K shares at avg. $94.43$1.4M - Dec 3, 2025GRAL
GRAIL, Inc.
Sale(S)Direct15.4K shares at avg. $95.28$1.5M - Dec 3, 2025GRAL
GRAIL, Inc.
Sale(S)Direct8.2K shares at avg. $96.22$792K - Dec 3, 2025GRAL
GRAIL, Inc.
Sale(S)Direct1.6K shares at avg. $97.28$156K - Oct 15, 2025GRAL
GRAIL, Inc.
Sale(S)Direct7.2K shares at avg. $68.88$499K - May 2, 2025GRAL
GRAIL, Inc.
Sale(S)Direct94K shares at avg. $33.93$3.2M - Mar 11, 2025GRAL
GRAIL, Inc.
Sale(S)Direct7.6K shares at avg. $31.21$238K - Mar 7, 2025GRAL
GRAIL, Inc.
Sale(S)Direct7.6K shares at avg. $31.21$238K - Mar 5, 2025GRAL
GRAIL, Inc.
Sale(S)Direct994 shares at avg. $41.51$41K - Feb 5, 2025TWST
Twist Bioscience Corp
Award(A)Direct4.5K shares- - Feb 3, 2025GRAL
GRAIL, Inc.
Award(A)Direct224.6K shares at avg. $28.84$6.5M - Oct 15, 2024GRAL
GRAIL, Inc.
Sale(S)Direct123.5K shares at avg. $14.02$1.7M - Oct 3, 2024GRAL
GRAIL, Inc.
Award(A)Direct45.8K shares at avg. $12.57$576K - Oct 3, 2024GRAL
GRAIL, Inc.
Award(A)Direct214.2K shares at avg. $12.57$2.7M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 |  ALMR Alamar Biosciences, Inc. | Award(A) | 5,686 | - | $0 | Direct |
| Apr 8, 2026 |  GRAL GRAIL, Inc. | Sale(S) | 123,502 | $49.92 | $6,164,923 | Direct |
| Mar 9, 2026 | GRAL GRAIL, Inc. | Sale(S) | 7,203 | $47.93 | $345,240 | Direct |
| Mar 9, 2026 | GRAL GRAIL, Inc. | Sale(S) | 258 | $46.73 | $12,056 | Direct |
| Mar 5, 2026 | GRAL GRAIL, Inc. | Sale(S) | 980 | $53.01 | $51,950 | Direct |
| Mar 2, 2026 | GRAL GRAIL, Inc. | Sale(S) | 35,787 | $50.09 | $1,792,403 | Direct |
| Mar 2, 2026 | GRAL GRAIL, Inc. | Sale(S) | 1,717 | $51.84 | $89,014 | Direct |
| Feb 5, 2026 |  TWST Twist Bioscience Corp | Award(A) | 5,095 | - | $0 | Direct |
| Dec 3, 2025 | GRAL GRAIL, Inc. | Sale(S) | 14,807 | $94.43 | $1,398,249 | Direct |
| Dec 3, 2025 | GRAL GRAIL, Inc. | Sale(S) | 15,356 | $95.28 | $1,463,092 | Direct |
| Dec 3, 2025 | GRAL GRAIL, Inc. | Sale(S) | 8,233 | $96.22 | $792,152 | Direct |
| Dec 3, 2025 | GRAL GRAIL, Inc. | Sale(S) | 1,604 | $97.28 | $156,042 | Direct |
| Oct 15, 2025 | GRAL GRAIL, Inc. | Sale(S) | 7,239 | $68.88 | $498,622 | Direct |
| May 2, 2025 | GRAL GRAIL, Inc. | Sale(S) | 94,035 | $33.93 | $3,190,608 | Direct |
| Mar 11, 2025 | GRAL GRAIL, Inc. | Sale(S) | 7,625 | $31.21 | $237,976 | Direct |
| Mar 7, 2025 | GRAL GRAIL, Inc. | Sale(S) | 7,625 | $31.21 | $237,976 | Direct |
| Mar 5, 2025 | GRAL GRAIL, Inc. | Sale(S) | 994 | $41.51 | $41,261 | Direct |
| Feb 5, 2025 | TWST Twist Bioscience Corp | Award(A) | 4,472 | - | - | Direct |
| Feb 3, 2025 | GRAL GRAIL, Inc. | Award(A) | 224,620 | $28.84 | $6,478,041 | Direct |
| Oct 15, 2024 | GRAL GRAIL, Inc. | Sale(S) | 123,454 | $14.02 | $1,730,825 | Direct |
| Oct 3, 2024 | GRAL GRAIL, Inc. | Award(A) | 45,840 | $12.57 | $576,209 | Direct |
| Oct 3, 2024 | GRAL GRAIL, Inc. | Award(A) | 214,240 | $12.57 | $2,692,997 | Direct |
1-22 of 22 transactions
About RAGUSA ROBERT P
RAGUSA ROBERT P (SEC CIK 0001222644) files insider reports with the SEC as Director of Alamar Biosciences, Inc. (ALMR), Chief Executive Officer of GRAIL, Inc. (GRAL) and Director of Twist Bioscience Corp (TWST).
Signal8 holds 16 ownership filings by RAGUSA ROBERT P (1 Form 3, 15 Form 4), filed between Oct 7, 2024 and Sep 3, 2026. Those filings report 22 transactions, from Oct 3, 2024 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on RAGUSA ROBERT P's filings is in FREMONT, CA.
Recent filings by RAGUSA ROBERT P
- Sep 1, 2026: Grant or award of ALMR shares (Form 4, code A).
- Apr 8, 2026: Open-market sale of GRAL shares (Form 4, code S).
- Mar 9, 2026: Open-market sales of GRAL shares (2 lines, Form 4, code S).
- Mar 5, 2026: Open-market sale of GRAL shares (Form 4, code S).
- Mar 2, 2026: Open-market sales of GRAL shares (2 lines, Form 4, code S).
Other insiders filing for Alamar Biosciences, Inc. (ALMR)
- Qiming Corporate GP VI, Ltd., 10% Owner
- Brottem John L., General Counsel
- Illumina Innovation Fund II GP, L.L.C., 10% Owner
- Chambers Rebecca, Director
- Witney Frank, Director
- White Timothy Ogden, President